03.08.2021 14:00

ERT's Ellen Street Named to PharmaVOICE 100 List of Most Inspiring Life Sciences Leaders


PHILADELPHIA, Aug. 3, 2021 /PRNewswire/ -- ERT, the global leader in clinical endpoint data collection, announced today that Ellen Street, Executive Vice President, Product and Quality Management, has been named one of 2021's 100 most inspiring individuals in the life sciences industry by PharmaVOICE. Representing a broad cross-section of industry sectors, PharmaVOICE 100 honorees are nominated by colleagues and selected based on their track record of inspiring others and affecting positive change in their organizations and the industry. 

Ellen Street, ERT Executive Vice President, Product and Quality Management, and 2021 PharmaVOICE Honoree

PharmaVOICE recognized Ellen for her authentic leadership approach and her ability to convert challenges to opportunities. She has driven significant improvements in clinical trial technologies and methodologies, enabling more efficient study designs, reduced study timelines and more confidence in trial safety.

"Ellen's leadership at ERT, which has been integral to ensuring the credibility of clinical trial data with the highest quality of evidence, inspires her teams and colleagues," said Taren Grom, editor, and co-founder of PharmaVOICE. "Her focus on implementing transformative initiatives and generating innovative ideas and solutions that impact the future of clinical trials and improve worldwide patient health are just some of the reasons why Ellen epitomizes what it takes to be a PharmaVOICE 100."

Ellen models accountability, collaboration and inclusiveness. She is passionate about challenging cross-functional teams to leverage processes, technologies and new ideas to deliver offerings with value propositions meaningful to customers and patients.  

"I love to instill a sense of purpose and desire to go above and beyond," said Ellen of her leadership style. "I challenge team members to take a broad view and make sure they understand the interdependencies of their decisions."

In addition to leading her teams, Ellen serves as a mentor at ERT and actively engages in sponsoring the next generation of leaders. She benefits from mutual learning and enjoys observing colleagues take new paths that lead to exciting opportunities and the ability to overcome obstacles and succeed.

To learn more about Ellen's impact at ERT and the industry at large, read the full feature from this month's issue of PharmaVOICE.

About ERT
ERT (eResearch Technology) is a global market leader and innovator in clinical trial endpoint data solutions, providing clinical study teams with the powerful and accurate data and digital results required to transform clinical trials. With nearly 50 years of clinical and therapeutic experience, ERT's mission is to "Transform Lives by Unlocking Better Evidence."

In 2021, ERT merged with Bioclinica to unite Bioclinica's expertise in imaging, eClinical software and drug safety solutions with ERT's expertise in eCOA, cardiac safety, respiratory and wearables. The combined company has thirty-one offices in eight countries. The global pharmaceutical industry has relied on its solutions across 23,000 studies, spanning more than five million patients and resulting in over 870 drug approvals to date. Since 2019, 70% of all FDA drug approvals came from ERT-supported studies.

ERT Media Contact
Terry Stanulis
Director, Public Relations and Thought Leadership
+1 (862) 288-0329


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/erts-ellen-street-named-to-pharmavoice-100-list-of-most-inspiring-life-sciences-leaders-301346530.html


Jetzt kostenlos anmelden!

Das Motto "so wenig wie möglich, so viel wie nötig" kann auch im Trading funktionieren. Im Trading-Seminar heute um 18 Uhr erfahren Sie, wie Sie mit nur drei Minuten pro Woche eine erfolgreiche Strategie handeln und dabei eine stabile Rendite erwirtschaften.
Jetzt kostenlos anmelden!
Börse Stuttgart Anlegerclub

Heute im Fokus

DAX stabil im Plus -- Asiens Börsen schließen fester -- Evergrande-Aktie mit Kurssprung -- BioNTech/Pfizer-Vakzin: FDA erlaubt Auffrischungsimpfung für Risikogruppen -- Lufthansa, Continental im Fokus

Deutsche Bank vorerst mit Umbau und nicht mit Übernahmen beschäftigt. HELLA senkt Prognose für Umsatz und operative Gewinnmarge im Gesamtjahr. Norwegens Notenbank hebt Leitzins erstmals seit Beginn der Pandemie an. EuGH-Gutachten sieht rechtswidrige Thermofenster bei Volkswagen-Autos. Nordex erhält Auftrag aus Polen. Schweizer Notenbank behält rekordtiefen Negativzins bei. Rheinmetall treibt Wasserstoffstrategie weiter voran.


Würden Sie es für richtig halten, wenn Gastronomie und Veranstaltungen nur noch Geimpften und Genesenen offen stehen?

finanzen.net zero
finanzen.net zero



Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln